Explore the words cloud of the ADJUV-ANT VACCINES project. It provides you a very rough idea of what is the project "ADJUV-ANT VACCINES" about.
The following table provides information about the project.
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS
|Coordinator Country||Spain [ES]|
|Total cost||1˙499˙218 €|
|EC max contribution||1˙499˙218 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2017-03-01 to 2022-02-28|
Take a look of project's partnership.
|1||ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS||ES (DERIO VIZCAYA)||coordinator||1˙499˙218.00|
The clinical success of anticancer and antiviral vaccines often requires the use of an adjuvant, a substance that helps stimulate the body’s immune response to the vaccine, making it work better. However, few adjuvants are sufficiently potent and non-toxic for clinical use; moreover, it is not really known how they work. Current vaccine approaches based on weak carbohydrate and glycopeptide antigens are not being particularly effective to induce the human immune system to mount an effective fight against cancer. Despite intensive research and several clinical trials, no such carbohydrate-based antitumor vaccine has yet been approved for public use. In this context, the proposed project has a double, ultimate goal based on applying chemistry to address the above clear gaps in the adjuvant-vaccine field. First, I will develop new improved adjuvants and novel chemical strategies towards more effective, self-adjuvanting synthetic vaccines. Second, I will probe deeply into the molecular mechanisms of the synthetic constructs by combining extensive immunological evaluations with molecular target identification and detailed conformational studies. Thus, the singularity of this multidisciplinary proposal stems from the integration of its main objectives and approaches connecting chemical synthesis and chemical/structural biology with cellular and molecular immunology. This ground-breaking project at the chemistry-biology frontier will allow me to establish my own independent research group and explore key unresolved mechanistic questions in the adjuvant/vaccine arena with extraordinary chemical precision. Therefore, with this transformative and timely research program I aim to (a) develop novel synthetic antitumor and antiviral vaccines with improved properties and efficacy for their prospective translation into the clinic and (b) gain new critical insights into the molecular basis and three-dimensional structure underlying the biological activity of these constructs.
|year||authors and title||journal||last update|
Mattia Ghirardello, Ane Ruiz-de-Angulo, Nagore Sacristan, Diego Barriales, JesÃºs JimÃ©nez-Barbero, Ana Poveda, Francisco Corzana, Juan Anguita, Alberto FernÃ¡ndez-Tejada
Exploiting structureâ€“activity relationships of QS-21 in the design and synthesis of streamlined saponin vaccine adjuvants
published pages: 719-722, ISSN: 1359-7345, DOI: 10.1039/c9cc07781b
|Chemical Communications 56/5||2020-02-12|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ADJUV-ANT VACCINES" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "ADJUV-ANT VACCINES" are provided by the European Opendata Portal: CORDIS opendata.
The Enemy of the Good: Towards a Theory of Moral ProgressRead More
Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin DomainsRead More
High throughput multiplexed trace-analyte screening for diagnostics applicationsRead More